Medicare drug price negotiations need something new: a floor
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by introducing floors.
Trump Impact on Medicare Drug Price Negotiations Uncertain
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and experimental pricing models for gene therapies. But so far the healthcare elements of the Inflation Reduction Act remain unchanged.
Trump rolls back effort to lower Medicare, Medicaid drug costs
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
Yes, Trump rescinded Biden's order to lower prescription drug costs for people on Medicare and Medicaid
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.
Medicare, Medicaid Out-of-Pocket Drug Costs Expected to Increase
The directive for the Department of Health and Human Services to develop and test new models aimed at lowering drug costs through the
Trump Revokes Biden's Order to Lower Drug Prices for Medicare
President Trump rescinded a Biden-era Executive Order that would have lowered the copays for some drugs to $2 for Medicare enrollees.
Modern Healthcare5h
CMS appeals UnitedHealth's Medicare Advantage Star Ratings win
In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...
CMS to seek Medicare negotiations on Ozempic price
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
Health Affairs3h
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
Modern Healthcare6d
CMS retracts Medicare Advantage enrollment report
The Centers for Medicare and Medicaid Services will issue corrected data on Medicare Advantage enrollment the week of Jan. 20 ...
If You Don’t Have Medicare Part B, The GEP Can Bail You Out
The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.
Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
CMS Crackdown on Medicare Plan-Switching Scams
Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.
McKnight's Long-Term Care News2h
BREAKING: ‘Crippling’ effects possible as CDC, CMS, other health communications paused
Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in ...